Stock UniverseDerived research view · source repositories remain read-only

Cardiff Oncology, Inc. (CRDF)

Therapeutics / Biopharma · Healthcare / Biotechnology
Score Band
Speculative
Selection Score
21.12
Global Rank
3219
Market Cap
132.63M
Latest Close
1.50
RS Composite
-33.72% · G#3101

Price Movement

3Y daily adjusted close
Loading price data...
Adjusted close SMA60D
1M
-10.71%
3M
-20.21%
6M
-29.58%
1Y
-58.56%
3Y
-6.83%
5Y
-82.14%
10Y
-99.60%

Volume

Loading volume data...
Volume Volume MA20D

Latest volume: 2.82M · 30-day average: 1.30M · Max drawdown over stored range: -99.82%

Research Snapshot

Relative Strength vs SPX

RS Composite-33.72%
20D RS-6.89%
60D RS-34.35%
120D RS-46.51%
Global RS Rank3101 · 7.57% percentile
Watch+Speculative RS Rank1908 · 9.01% percentile
Group ScopeWatch+Speculative
Primary RS Rank381 · 16.81% percentile
Snapshot Date2026-06-05

RS uses adjusted close where available. Global RS Rank is recalculated from the current non-low pool. Group RS Rank is recalculated inside the company’s own actionable band group.

Research Links

StockAnalysis
Yahoo Finance
Perplexity Finance
Finviz
Seeking Alpha
WhaleWisdom
FinanceCharts
SEC EDGAR Search
SEC Company Search

Official company website and investor-relations URLs are not inferred unless a reliable dynamic source is added.

Classification

Primary Rank420 / 701
Primary Percentile40.23
Score Notesmarket-cap support, industry-tailwind, microcap penalty

Gemini Deep Research

Loading Gemini reports...

Manual Estimates

Loading manual estimates...

Forward Valuation

Loading forward valuation...

SEC TTM Fundamentals

No processed TTM rows for CRDF.

TTM Valuation

No SEC TTM valuation available.

Financial Statement Metrics

MetricFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Revenue0.3660.3590.3860.4880.6830.593
Revenue Growth (YoY)49.612%-1.913%7.521%26.425%39.959%-13.177%
Gross Profit-10.869-17.017-26.721-32.369-36.169
Operating Income-19.086-28.855-39.902-45.412-48.651
Free Cash Flow-16.526-23.245-34.826-31.469-37.773-37.967
Free Cash Flow Per Share-0.792-0.596-0.799-0.704-0.793-0.5680196286710253
EPS (Diluted) GAAP-1.082538-0.725467-0.888256-0.928106-0.953934
EPS Growth
EPS Non-GAAP
Gross Margin100%100%100%100%100%
Operating Margin-5214.754%-8037.604%-10337.306%-9305.738%-7123.133%-8256.3238%
Profit Margin-6174.317%-7887.187%-10033.161%-8496.926%-6655.198%-7732.0405%
Free Cash Flow Margin-4515.301%-6474.93%-9022.28%-6448.566%-5530.454%-6402.5295%
Shares Outstanding (Diluted)20.87539.0343.644.67747.6566.841
Shares Change (YoY)249.436%86.97%11.709%2.47%6.654%40.275%

SEC Quarterly Fundamentals

No processed quarterly rows for CRDF.